FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. (Q52886599)

9 May 2018

title

FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. (English)

1 reference

9 May 2018

Adaptive radiation therapy

main subject

0 references

Nicolas Jansen

8

0 references

Roland Hustinx

10

object named as

Roland Hustinx

1 reference

9 May 2018

Dimitris Visvikis

7

object named as

Dimitris Visvikis

1 reference

9 May 2018

author name string

Pierre Lovinfosse

1

1 reference

9 May 2018

Zsolt Levente Janvary

2

1 reference

9 May 2018

Philippe Coucke

3

1 reference

9 May 2018

Sébastien Jodogne

4

1 reference

9 May 2018

Claire Bernard

5

1 reference

9 May 2018

Mathieu Hatt

6

1 reference

9 May 2018

Bernard Duysinx

9

1 reference

9 May 2018

publication date

30 January 2016

1 reference

9 May 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

9 May 2018

volume

43

1 reference

9 May 2018

issue

8

1 reference

9 May 2018

page(s)

1453-1460

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1007/s00259-016-3314-8

exact match

0 references

cites work

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Natural history of stage I non-small cell lung cancer: implications for early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Lung cancer: progress in diagnosis, staging and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Noninvasive staging of non-small cell lung cancer: a review of the current evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

PET scans in radiotherapy planning of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Maximum standardized uptake value on FDG-PET is a strong predictor of overall and disease-free survival for non-small-cell lung cancer patients after stereotactic body radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Visual versus quantitative assessment of intratumor 18F-FDG PET uptake heterogeneity: prognostic value in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

PET functional volume delineation: a robustness and repeatability study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Exploring feature-based approaches in PET images for predicting cancer treatment outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Quantitatively characterizing the textural features of sonographic images for breast cancer with histopathologic correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3314-8

Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer

21 January 2018

1 reference

12 December 2020

Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis.

1 reference

12 December 2020

Relationship between pretreatment FDG uptake and local control after stereotactic body radiotherapy in stage I non-small-cell lung cancer: the preliminary results

1 reference

12 December 2020

Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors

1 reference

12 December 2020

10.1007/S00259-016-3314-8

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

26830299

1 reference

9 May 2018